- $12.70bn
- $35.68bn
- $10.82bn
Brief: Japan’S SMFG Readies Itself For Possible Takeover Of Jefferies- FT
Apogee Therapeutics dips after announcing planned $300 mln stock sale
UK regulator launches probe into collapsed lender MFS (updated)
CytomX drops on $250 mln equity raise
SAB Biotherapeutics slips on $85 mln equity offering
SAB Biotherapeutics falls after launching stock offering
CytomX retreats ahead of planned $250 mln equity raise after promising cancer drug data
CytomX dips after launching stock offering following colorectal cancer drug data
Factbox: From Blue Owl to First Brands: flashpoints in credit markets
Logistics firm GLP seeks $20 billion valuation in planned Hong Kong IPO, sources say
Dianthus Therapeutics slips premarket after increased $625 mln share sale
First Brands row hints at banks’ shadow exposure
Dianthus Therapeutics slips after starting $400 mln stock sale
U.S. STOCKS ON THE MOVE-Hewlett Packard Enterprise, Dianthus, 3D Systems
U.S. STOCKS ON THE MOVE-Biotechs, Agilent, Dow
Jefferies falls after Morgan Stanley downgrades stock
Brief: Jefferies Discloses Facts About Western Alliance and Western Alliance’s Loan Solely Against First Brands Receivables
Jefferies expects less than $20 million hit from exposure to UK mortgage lender MFS (updated)
Jefferies expects less than $20 million hit from exposure to UK mortgage lender MFS